Morris TA - Search Results

1

Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch JRE, Wells P, Woller SC, Moores L. Kearon C, et al. Among authors: morris ta. Chest. 2016 Feb;149(2):315-352. doi: 10.1016/j.chest.2015.11.026. Epub 2016 Jan 7. Chest. 2016. PMID: 26867832

2

Heparin and low molecular weight heparin: background and pharmacology.

Morris TA. Morris TA. Clin Chest Med. 2003 Mar;24(1):39-47. doi: 10.1016/s0272-5231(02)00053-9. Clin Chest Med. 2003. PMID: 12685055 Review.

3

No difference in risk for thrombocytopenia during treatment of pulmonary embolism and deep venous thrombosis with either low-molecular-weight heparin or unfractionated heparin: a metaanalysis.

Morris TA, Castrejon S, Devendra G, Gamst AC. Morris TA, et al. Chest. 2007 Oct;132(4):1131-9. doi: 10.1378/chest.06-2518. Epub 2007 Jul 23. Chest. 2007. PMID: 17646239

4

New synthetic antithrombotic agents for venous thromboembolism: pentasaccharides, direct thrombin inhibitors, direct Xa inhibitors.

Morris TA. Morris TA. Clin Chest Med. 2010 Dec;31(4):707-18. doi: 10.1016/j.ccm.2010.06.006. Clin Chest Med. 2010. PMID: 21047577 Review.

5

Accuracy and safety of (99m)Tc-labeled anti-D-dimer (DI-80B3) Fab' fragments (ThromboView®) in the diagnosis of deep vein thrombosis: a phase II study.

Douketis JD, Ginsberg JS, Haley S, Julian J, Dwyer M, Levine M, Eisenberg PR, Smart R, Tsui W, White RH, Morris TA, Kaatz S, Comp PC, Crowther MA, Kearon C, Kassis J, Bates SM, Schulman S, Desjardins L, Taillefer R, Begelman SM, Gerometta M. Douketis JD, et al. Among authors: morris ta. Thromb Res. 2012 Sep;130(3):381-9. doi: 10.1016/j.thromres.2012.05.011. Epub 2012 Jun 1. Thromb Res. 2012. PMID: 22658414 Clinical Trial.

6

Response.

Morris TA, Porszasz J, Stringer WW. Morris TA, et al. Chest. 2020 Oct;158(4):1781-1782. doi: 10.1016/j.chest.2020.07.037. Chest. 2020. PMID: 33036092 No abstract available.

7

Observational cohort study to validate SEARCH, a novel hierarchical algorithm to define long-term outcomes after pulmonary embolism.

Morris TA, Fernandes TM, Chung J, Vintch JRE, McGuire WC, Thapamagar S, Alotaibi M, Aries S, Dakaeva K. Morris TA, et al. BMJ Open. 2023 Sep 28;13(9):e074470. doi: 10.1136/bmjopen-2023-074470. BMJ Open. 2023. PMID: 37770267 Free PMC article.

8

Parenchymal scarring is associated with restrictive spirometric defects in patients with chronic thromboembolic pulmonary hypertension.

Morris TA, Auger WR, Ysrael MZ, Olson LK, Channick RN, Fedullo PF, Moser KM. Morris TA, et al. Chest. 1996 Aug;110(2):399-403. doi: 10.1378/chest.110.2.399. Chest. 1996. PMID: 8697841

9

Antithrombotic therapy for venous thromboembolic disease.

Hyers TM, Agnelli G, Hull RD, Morris TA, Samama M, Tapson V, Weg JG. Hyers TM, et al. Among authors: morris ta. Chest. 2001 Jan;119(1 Suppl):176S-193S. doi: 10.1378/chest.119.1_suppl.176s. Chest. 2001. PMID: 11157648 Review. No abstract available.

10

Pulmonary embolism during and after pregnancy.

Stone SE, Morris TA. Stone SE, et al. Among authors: morris ta. Crit Care Med. 2005 Oct;33(10 Suppl):S294-300. doi: 10.1097/01.ccm.0000183157.15533.4c. Crit Care Med. 2005. PMID: 16215350 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page